Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

METFORMIN\VILDAGLIPTIN for Type 1 diabetes mellitus: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 7 adverse event reports in the FDA FAERS database where METFORMIN\VILDAGLIPTIN was used for Type 1 diabetes mellitus.

Most Reported Side Effects for METFORMIN\VILDAGLIPTIN

Side Effect Reports % Deaths Hosp.
Blood glucose increased 346 12.0% 4 81
Lactic acidosis 279 9.7% 33 171
Hyperglycaemia 236 8.2% 1 30
Acute kidney injury 191 6.6% 12 112
Diabetes mellitus 189 6.5% 5 26
Malaise 186 6.4% 6 66
Hypertension 163 5.6% 6 26
Diarrhoea 152 5.3% 2 53
Diabetes mellitus inadequate control 137 4.7% 1 19
Glycosylated haemoglobin increased 136 4.7% 0 12
Weight decreased 133 4.6% 2 39
Blood pressure increased 126 4.4% 2 31
Vomiting 123 4.3% 2 78
Hypoglycaemia 117 4.1% 10 45
Drug ineffective 113 3.9% 1 26

Other Indications for METFORMIN\VILDAGLIPTIN

Diabetes mellitus (1,291) Type 2 diabetes mellitus (726) Product used for unknown indication (691) Blood glucose increased (45) Blood glucose abnormal (44) Diabetes mellitus management (16) Hyperglycaemia (8) Hypertension (7) Blood glucose (6) Glucose tolerance impaired (6)

Other Drugs Used for Type 1 diabetes mellitus

INSULIN LISPRO (9,401) INSULIN GLARGINE (6,569) INSULIN ASPART (3,913) INSULIN HUMAN (2,150) INSULIN DEGLUDEC (1,459) INSULIN DETEMIR (794) INSULIN GLULISINE (569) DEVICE (495) CANAGLIFLOZIN (422) EMPAGLIFLOZIN (383)

Related Pages

METFORMIN\VILDAGLIPTIN Full Profile All Type 1 diabetes mellitus Drugs METFORMIN\VILDAGLIPTIN Demographics METFORMIN\VILDAGLIPTIN Timeline